David Margolis
About David Margolis
David Margolis: Chief Medical Officer
David Margolis currently holds the position of Chief Medical Officer. His extensive experience in the field of medicine and leadership roles within major healthcare companies highlight his capacity for guiding clinical development strategies and overseeing significant healthcare projects.
David Margolis' Previous Roles at GSK and ViiV Healthcare
David Margolis previously served as Medical Director and Senior Medical Director at both GSK and ViiV Healthcare. During his tenure, he was instrumental in leading the clinical development program for the long-acting integrase inhibitor, cabotegravir. His work included creating and executing the strategic plan for the clinical development of the first long-acting HIV treatment regimen, CAB+RPV.
David Margolis' Education and Expertise
David Margolis received his M.D. from Duke University School of Medicine and earned a Masters of Public Health from the University of North Carolina at Chapel Hill. He completed his Internal Medicine residency at the University of Colorado Health Science Center and a fellowship in Infectious Diseases at the University of California at San Diego in La Jolla. His research focuses predominantly on infectious diseases in immunocompromised hosts.
David Margolis' Clinical Collaborations
David Margolis has overseen multiple clinical collaborations involving Janssen Pharmaceuticals, IMPAACT, and the ACTG. These projects underline his ability to manage and coordinate complex clinical research partnerships, contributing to the advancement of treatments for infectious diseases.
David Margolis' Role at Duke University Medical Center
David Margolis maintained a clinical ID practice as an Assistant Consulting Professor in the Infectious Diseases Department at Duke University Medical Center for 8 years. His role included both treating patients and contributing to the academic and clinical research environment at Duke University.